GALMED PHARMACEUTICALS LTD. Restricted Cash, Current
GALMED PHARMACEUTICALS LTD. (GLMD) had Restricted Cash, Current of $159.00 thousand as of 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-09-02
- 2026-06-30: Restricted Cash, Current $159.00K.
- 2025-12-31: Restricted Cash, Current $124.00K.
- 2025-09-30: Restricted Cash, Current $124.00K.
- 2025-06-30: Restricted Cash, Current $123.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $159.00K 6-K · filed 2026-09-02 |
| 2025-12-31 | $124.00K 6-K · filed 2026-09-02 |
| 2025-09-30 | $124.00K 6-K · filed 2025-11-26 |
| 2025-06-30 | $123.00K 6-K · filed 2025-08-28 |
| 2024-12-31 | $121.00K 20-F · filed 2026-03-31 |
| 2024-06-30 | $118.00K 6-K · filed 2024-08-28 |
| 2023-12-31 | $117.00K 20-F · filed 2025-04-02 |
| 2023-06-30 | $115.00K 6-K · filed 2023-08-09 |
| 2022-12-31 | $114.00K 20-F · filed 2024-04-04 |
| 2022-06-30 | $114.00K 6-K · filed 2022-08-04 |
| 2021-12-31 | $114.00K 20-F · filed 2023-03-29 |
| 2021-06-30 | $113.00K 6-K · filed 2021-08-05 |
| 2020-12-31 | $113.00K 20-F · filed 2022-05-02 |
| 2020-06-30 | $113.00K 6-K · filed 2020-08-06 |
| 2019-12-31 | $112.00K 20-F · filed 2021-03-18 |
| 2018-12-31 | $0.00 20-F · filed 2020-03-12 |